FIELD: biotechnology.
SUBSTANCE: invention relates to a method for inducing differentiation of stem cells into dopaminergic progenitor cells. Also a method for the mass production of dopaminergic neural progenitor cells is disclosed.
EFFECT: invention is effective for use in cell therapy.
14 cl, 13 dwg, 2 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PRODUCING RENAL PROGENITOR CELLS AND MEDICINAL AGENT CONTAINING SAME | 2014 |
|
RU2696315C2 |
| METHODS OF DERIVING DIFFERENTIATED CELLS FROM STEM CELLS | 2009 |
|
RU2576003C2 |
| METHOD FOR PREPARING PANCREATIC HORMONE-PRODUCING CELLS | 2011 |
|
RU2576000C2 |
| METHOD FOR PLURIPOTENT STEM CELLS DIFFERENTIATION INTO VASCULAR BED CELLS | 2012 |
|
RU2618871C2 |
| DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS | 2011 |
|
RU2620938C2 |
| PRODUCTION OF TERMINAL-DIFFERENTIATED DOFAMINNERGIC NEURONES FROM EMBRIONIC HUMAN FOUNDER CELLS | 2004 |
|
RU2345133C2 |
| DIFFERENTIATION OF PLURIPOTENT STEM CELLS | 2011 |
|
RU2599420C2 |
| DIFFERENTIATION OF PLURIPOTENT STEM CELLS | 2011 |
|
RU2673946C1 |
| METHOD FOR ASSESSING NEUROPROTECTIVE PROPERTIES OF VITRO SUBSTANCES AND THE TEST SYSTEM FOR ITS IMPLEMENTATION | 2016 |
|
RU2646446C1 |
| DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS | 2011 |
|
RU2627168C2 |
